Key result
Prostaglandin E1 administration in infants with ductus dependent cardiac malformations resulted in pronounced pathological changes in the ductus arteriosus, rendering the vessel prone to laceration.
Why the study?
Does Prostaglandin E1 (PGE1) administration affect the histology of the ductus arteriosus in infants with ductus dependent cardiac malformations?
Population
4 infants with ductus dependent cardiac malformations
Design
Case_series
Authors
Loading...
May warrant caution in ductal manipulation after PGE1; case report leaves open clinical risk and causality.
Case Report (n=4)
Does Prostaglandin E1 (PGE1) administration affect the histology of the ductus arteriosus in infants with ductus dependent cardiac malformations?
Prostaglandin E1 administration in infants with ductus-dependent cardiac anomalies is associated with pronounced histological changes that weaken the ductus arteriosus wall, potentially increasing the risk of laceration.
Groot et al. (1978) conducted a case report in Ductus dependent cardiac malformations (n=4). Prostaglandin E1 (PGE1) was evaluated on Histology of the ductus arteriosus. Prostaglandin E1 administration in infants with ductus dependent cardiac malformations resulted in pronounced pathological changes in the ductus arteriosus, rendering the vessel prone to laceration.
Synapse has enriched 2 closely related papers on similar clinical questions. Consider them for comparative context: